Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
31 active trials across 3 therapeutic areas
31
Active Trials
12
Phase 1
12
Phase 2
10
Phase 3
3
Therapeutic Areas
Portfolio Concentration: 87% of active trials in Oncology
Oncology
27 active / 31 total
Solid Tumor (Advanced)
10 active
12 total since 2015
NSCLC
5 active
4 Ph3
5 total since 2015
Breast Cancer
4 active
2 Ph3
4 total since 2015
Lung Cancer (General)
3 active
3 total since 2015
Triple Negative Breast Cancer
3 active
2 Ph3
3 total since 2015
SCLC
1 active
1 total since 2015
HER2+ Breast Cancer
1 active
1 Ph3
1 total since 2015
Colorectal Cancer
0 active
1 total since 2015
Hodgkin Lymphoma
0 active
1 total since 2015
Immunology
2 active / 3 total
Cardiovascular
1 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)